Virax Biolabs Group Ltd (VRAX) Shares Outstanding (Weighted Average) (2021 - 2025)

Virax Biolabs (VRAX) has 5 years of Shares Outstanding (Weighted Average) data on file, last reported at $4342.0 in Q1 2025.

• In Q1 2025, Shares Outstanding (Weighted Average) rose 68.69% year-over-year to $4342.0; the TTM figure through Mar 2025 stood at $4342.0 (up 68.69% YoY), while the FY2025 annual figure was $4342.0, up 68.69% from the prior year.
• Shares Outstanding (Weighted Average) improved to $4342.0 in Q1 2025, from $2574.0 in the prior quarter.
• Across five years, Shares Outstanding (Weighted Average) topped out at $290364.0 in Q1 2022 and bottomed at $223.0 in Q1 2021.
• A 5-year average of $59812.0 and a median of $2574.0 in 2024 frame the typical range for Shares Outstanding (Weighted Average).
• Annual changes were most pronounced in 2022 — Shares Outstanding (Weighted Average) surged 130108.07% — and 2023, when it tumbled 99.46%.
• Year by year, Shares Outstanding (Weighted Average) stood at $223.0 in 2021, then surged by 130108.07% to $290364.0 in 2022, then tumbled by 99.46% to $1557.0 in 2023, then jumped by 65.32% to $2574.0 in 2024, then jumped by 68.69% to $4342.0 in 2025.
• The last three Shares Outstanding (Weighted Average) figures came in at $4342.0 (Q1 2025), $2574.0 (Q1 2024), and $1557.0 (Q1 2023), per Business Quant data.

Peer Comparison